Bot Detector
LEARN MORE
A subscription to
IJPC
provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.
LEARN MORE
Sign On
The Journal
Editor-In-Chief
Editorial Calendar
Submissions
Advertising
Permissions & Reprints
Privacy Policy
Contact Us
Subscribe
Renew
Prices
Free Sample
View Cart
Articles
Issues
Archives
Supplemental Content and Errata
Training and Education
IJPC-PCAB SOP Matrix
USP GAP Analysis
Compounders' Network List
Patient Information
Videos
Compounders' Resource Directory
Author Search Results
Author Search Results for "Riepl Mike"
Title/Author
(Click for Abstract / Details / Purchase)
Issue/Page
View/Buy
Heartworm-, Flea-, and Tick-associated Diseases in Dogs: A Review of Common Parasites and Drug Classes Prophylactic Against Them
Riepl Mike
May/Jun 2024
Pg. 188-193
Prophylaxis Against Heartworm Infection and Flea or Tick Infestation in Dogs: Single Agents and Combination-Drug Products
Riepl Mike
May/Jun 2024
Pg. 205-213
Compounded "Monster Spray" for Nighttime Terrors: A Case Report
Riepl Mike
Nov/Dec 2023
Pg. 446-448
Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment
Riepl Mike
,
Kaiser Joe
Sep/Oct 2023
Pg. 368-380
Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID
Riepl Mike
,
Kaiser Joe
Jul/Aug 2023
Pg. 284-293
Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development
Riepl Mike
,
Kaiser Joe
May/Jun 2023
Pg. 192-200
Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment
Riepl Mike
Mar/Apr 2023
Pg. 98-107
Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants
Riepl Mike
Jan/Feb 2023
Pg. 12-21
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
Jul/Aug 2022
Pg. 270-274
A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Riepl Mike
May/Jun 2022
Pg. 189-193
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98
A Compendium of Compounding Agents and Formulations, Part 1: Melatonin
Riepl Mike
Jan/Feb 2022
Pg. 18-23
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
Nov/Dec 2021
Pg. 468-472
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
Sep/Oct 2021
Pg. 372-377
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Riepl Mike
Jul/Aug 2021
Pg. 282-287
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Riepl Mike
Mar/Apr 2021
Pg. 100-103
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 278-281
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
Jul/Aug 2020
Pg. 282-285
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
May/Jun 2020
Pg. 182-186
Compounding Pearls -- Wound Care: Burn Healing, Part 1
Riepl Mike
May/Jun 2020
Pg. 188-193
Compounding Pearls -- Wound Care: Base Selection
Riepl Mike
Mar/Apr 2020
Pg. 98-102
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Riepl Mike
May/Jun 2019
Pg. 192-199
Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome
Riepl Mike
Nov/Dec 2018
Pg. 456-465
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Muller George
,
Grieshaber Robert
,
Talley J Floyd
,
Riepl Mike
,
Fellows Don
Jul/Aug 2018
Pg. 270-278
Return to Top